NeuroGenetic Pharmaceuticals' Debt - II Round

NeuroGenetic Pharmaceuticals raised a round of funding on March 12, 2015.

Neurogenetic Pharmaceuticals is a biopharmaceutical discovery and development company focused on developing drug therapies for use in the treatment of neurodegenerative disorders such as Alzheimer's d…

Articles about NeuroGenetic Pharmaceuticals' Debt - II Round: